Randomized phase II trial of the prophylactic use of celecoxib for the prevention of oxaliplatin-related peripheral vascular pain in Capeox (YCOG1205).

Yusuke SuwaJun WatanabeMitsuyoshi OtaShinsuke SuzukiHirokazu SuwaKazuteru WatanabeShuji SaitoKoutaro NagamineMasashi MomiyamaAtsushi IshibeYusuke SaigusaTakeharu YamanakaItaru Endo

Published in: Cancer chemotherapy and pharmacology (2018)

Celecoxib was unable to prevent oxaliplatin-related vascular pain in this study. However, it may be able to decrease the vascular pain that patients already have.

Keyphrases

chronic pain
pain management
neuropathic pain
end stage renal disease
open label
newly diagnosed
chronic kidney disease
prognostic factors
placebo controlled
double blind
clinical trial
randomized controlled trial
spinal cord
patient reported outcomes
postoperative pain
patient reported